218 related articles for article (PubMed ID: 37957138)
1. UBE4B interacts with the ITCH E3 ubiquitin ligase to induce Ku70 and c-FLIPL polyubiquitination and enhanced neuroblastoma apoptosis.
Le Clorennec C; Subramonian D; Huo Y; Zage PE
Cell Death Dis; 2023 Nov; 14(11):739. PubMed ID: 37957138
[TBL] [Abstract][Full Text] [Related]
2. The E3 ubiquitin ligase Itch and Yap1 have antagonistic roles in the regulation of ASPP2 protein stability.
Gao K; An J; Zhang Y; Jin X; Ma J; Peng J; Tang Y; Yu L; Zhang P; Wang C
FEBS Lett; 2015 Jan; 589(1):94-101. PubMed ID: 25436413
[TBL] [Abstract][Full Text] [Related]
3. The E3 ubiquitin ligase Itch regulates tumor suppressor protein RASSF5/NORE1 stability in an acetylation-dependent manner.
Suryaraja R; Anitha M; Anbarasu K; Kumari G; Mahalingam S
Cell Death Dis; 2013 Mar; 4(3):e565. PubMed ID: 23538446
[TBL] [Abstract][Full Text] [Related]
4. The E3/E4 ubiquitin conjugation factor UBE4B interacts with and ubiquitinates the HTLV-1 Tax oncoprotein to promote NF-κB activation.
Mohanty S; Han T; Choi YB; Lavorgna A; Zhang J; Harhaj EW
PLoS Pathog; 2020 Dec; 16(12):e1008504. PubMed ID: 33362245
[TBL] [Abstract][Full Text] [Related]
5. UBE4B, a ubiquitin chain assembly factor, is required for MDM2-mediated p53 polyubiquitination and degradation.
Wu H; Leng RP
Cell Cycle; 2011 Jun; 10(12):1912-5. PubMed ID: 21558803
[TBL] [Abstract][Full Text] [Related]
6. UBE4B levels are correlated with clinical outcomes in neuroblastoma patients and with altered neuroblastoma cell proliferation and sensitivity to epidermal growth factor receptor inhibitors.
Zage PE; Sirisaengtaksin N; Liu Y; Gireud M; Brown BS; Palla S; Richards KN; Hughes DP; Bean AJ
Cancer; 2013 Feb; 119(4):915-23. PubMed ID: 22990745
[TBL] [Abstract][Full Text] [Related]
7. The E3 ligase Aip4/Itch ubiquitinates and targets ErbB-4 for degradation.
Omerovic J; Santangelo L; Puggioni EM; Marrocco J; Dall'Armi C; Palumbo C; Belleudi F; Di Marcotullio L; Frati L; Torrisi MR; Cesareni G; Gulino A; Alimandi M
FASEB J; 2007 Sep; 21(11):2849-62. PubMed ID: 17463226
[TBL] [Abstract][Full Text] [Related]
8. Low UBE4B expression increases sensitivity of chemoresistant neuroblastoma cells to EGFR and STAT5 inhibition.
Memarzadeh K; Savage DJ; Bean AJ
Cancer Biol Ther; 2019; 20(12):1416-1429. PubMed ID: 31475882
[TBL] [Abstract][Full Text] [Related]
9. ITCH-dependent proteasomal degradation of c-FLIP induced by the anti-HER3 antibody 9F7-F11 promotes DR5/caspase 8-mediated apoptosis of tumor cells.
Le Clorennec C; Lazrek Y; Dubreuil O; Sampaio C; Larbouret C; Lanotte R; Poul MA; Barret JM; Prost JF; Pèlegrin A; Chardès T
Cell Commun Signal; 2019 Aug; 17(1):106. PubMed ID: 31443721
[TBL] [Abstract][Full Text] [Related]
10. HECT-Type Ubiquitin E3 Ligase ITCH Interacts With Thioredoxin-Interacting Protein and Ameliorates Reactive Oxygen Species-Induced Cardiotoxicity.
Otaki Y; Takahashi H; Watanabe T; Funayama A; Netsu S; Honda Y; Narumi T; Kadowaki S; Hasegawa H; Honda S; Arimoto T; Shishido T; Miyamoto T; Kamata H; Nakajima O; Kubota I
J Am Heart Assoc; 2016 Jan; 5(1):. PubMed ID: 26796253
[TBL] [Abstract][Full Text] [Related]
11. Phosphorylation of the E3 ubiquitin protein ligase ITCH diminishes binding to its cognate E2 ubiquitin ligase.
Perez JM; Chen Y; Xiao TS; Abbott DW
J Biol Chem; 2018 Jan; 293(3):1100-1105. PubMed ID: 29212706
[TBL] [Abstract][Full Text] [Related]
12. HECT-type ubiquitin ligase ITCH targets lysosomal-associated protein multispanning transmembrane 5 (LAPTM5) and prevents LAPTM5-mediated cell death.
Ishihara T; Inoue J; Kozaki KI; Imoto I; Inazawa J
J Biol Chem; 2011 Dec; 286(51):44086-44094. PubMed ID: 22009753
[TBL] [Abstract][Full Text] [Related]
13. HECT E3 Ubiquitin Ligase Itch Functions as a Novel Negative Regulator of Gli-Similar 3 (Glis3) Transcriptional Activity.
ZeRuth GT; Williams JG; Cole YC; Jetten AM
PLoS One; 2015; 10(7):e0131303. PubMed ID: 26147758
[TBL] [Abstract][Full Text] [Related]
14. Neuroblastoma patient outcomes, tumor differentiation, and ERK activation are correlated with expression levels of the ubiquitin ligase UBE4B.
Woodfield SE; Guo RJ; Liu Y; Major AM; Hollingsworth EF; Indiviglio S; Whittle SB; Mo Q; Bean AJ; Ittmann M; Lopez-Terrada D; Zage PE
Genes Cancer; 2016 Jan; 7(1-2):13-26. PubMed ID: 27014418
[TBL] [Abstract][Full Text] [Related]
15. UBE4B promotes Hdm2-mediated degradation of the tumor suppressor p53.
Wu H; Pomeroy SL; Ferreira M; Teider N; Mariani J; Nakayama KI; Hatakeyama S; Tron VA; Saltibus LF; Spyracopoulos L; Leng RP
Nat Med; 2011 Mar; 17(3):347-55. PubMed ID: 21317885
[TBL] [Abstract][Full Text] [Related]
16. Ubiquitination of Ku70 by Parkin promotes apoptosis of lens epithelial cells.
Zhang W; Wu A; Zhang G; Ding X; Kang L; Zhou T; Ji M; Guan H
FEBS J; 2023 Aug; 290(15):3828-3842. PubMed ID: 37000041
[TBL] [Abstract][Full Text] [Related]
17. Negative regulation of the Hippo pathway by E3 ubiquitin ligase ITCH is sufficient to promote tumorigenicity.
Salah Z; Melino G; Aqeilan RI
Cancer Res; 2011 Mar; 71(5):2010-20. PubMed ID: 21212414
[TBL] [Abstract][Full Text] [Related]
18. Itch self-polyubiquitylation occurs through lysine-63 linkages.
Scialpi F; Malatesta M; Peschiaroli A; Rossi M; Melino G; Bernassola F
Biochem Pharmacol; 2008 Dec; 76(11):1515-21. PubMed ID: 18718449
[TBL] [Abstract][Full Text] [Related]
19. Ubiquitin E3 ligase Itch negatively regulates osteoblast function by promoting proteasome degradation of osteogenic proteins.
Liu J; Li X; Zhang H; Gu R; Wang Z; Gao Z; Xing L
Bone Joint Res; 2017 Mar; 6(3):154-161. PubMed ID: 28298321
[TBL] [Abstract][Full Text] [Related]
20. The anti-HER3 (ErbB3) therapeutic antibody 9F7-F11 induces HER3 ubiquitination and degradation in tumors through JNK1/2- dependent ITCH/AIP4 activation.
Le Clorennec C; Lazrek Y; Dubreuil O; Larbouret C; Poul MA; Mondon P; Melino G; Pèlegrin A; Chardès T
Oncotarget; 2016 Jun; 7(24):37013-37029. PubMed ID: 27203743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
